Insys Therapeutics competitors

Insys Therapeutics's competitors include Depomed, Medivir, Delcath Systems and Bio-Path Holdings
Add company...
Insys Therapeutics
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.
Depomed
Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.
Medivir
Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.
Delcath Systems
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
Bio-Path Holdings
Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.
Founding Date
Founding Date
1998
Founding Date
1995
Founding Date
1988
Founding Date
1988
Founding Date
2007
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Chandler, US HQ
Round Rock, US
Chandler, US
Locations
Newark, US HQ
Locations
Huddinge, SE HQ
Locations
New York, US HQ
Queensbury, US
Galway, IE
Locations
Bellaire, US HQ
Employees
Employees
423
Employees
490
Employees
82
Employees
4310% increase
Employees
12
Valuation ($)
Valuation ($)
701.6 m
Valuation ($)
466.6 m
Valuation ($)
N/A
Valuation ($)
8 m
Valuation ($)
10.9 m

Financial

Revenue (est.)
Revenue (est.)
$140.7m (FY, 2017)
Revenue (est.)
$380.7m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$13k (FY, 2016)
Cost of goods
Cost of goods
$20.6m (FY, 2017)
Cost of goods
$72.6m (FY, 2017)
Cost of goods
N/A
Cost of goods
$550k (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
$120.1m (FY, 2017)
Gross profit
$308.1m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($228m) (FY, 2017)
Net income
($102.5m) (FY, 2017)
Net income
N/A
Net income
($18m) (FY, 2016)
Net income
($6.8m) (FY, 2016)

Funding

Total funding raised
Total funding raised
$ 2.3m
Total funding raised
$ 875m
Total funding raised
N/A
Total funding raised
$ 42m
Total funding raised
$ 2.3m
For sources of this data, please see the company profileDownload Excel

View company profiles

Depomed
HQ
Newark, US
Employees
490

Depomed is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other.

View company
Medivir
HQ
Huddinge, SE
Employees
82

Medivir researches, develops, and sells pharmaceuticals primarily for the treatment of oncology.

View company
Delcath Systems
HQ
New York, US
Employees
43↑ 10% increase

Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.

View company
Bio-Path Holdings
HQ
Bellaire, US
Employees
12

Bio-Path Holdings is a clinical and preclinical stage oncology focused antisense drug development company.

View company